Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Corti

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Tumori|June 13, 2020
Comparison of outcomes of central venous catheters in patients with solid and hematologic neoplasms: an Italian real-world analysisFrancesca Corti, Marta Brambilla, Sara Manglaviti, et al.
Cancers|April 10, 2019
Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-AnalysisSara Pusceddu, Michele Ghidini, Martina Torchio, et al.
The Oncologist|April 6, 2023
BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint InhibitorsRaphael Colle, Sara Lonardi, Marine Cachanado, et al.
Therapeutic Advances in Gastroenterology|August 22, 2020
The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidenceSara Pusceddu, Claudio Vernieri, Natalie Prinzi, et al.
Future Oncology (London, England)|August 20, 2019
Somatostatin analogs in association with peptide receptor radionucleotide therapy in advanced well-differentiated NETsNatalie Prinzi, Alessandra Raimondi, Marco Maccauro, et al.
Frontiers in Oncology|July 5, 2021
Case Report: Exceptional Response to Avelumab After Failure of Electrochemotherapy in a Patient With Rapidly Progressive, PD-L1-Negative Merkel Cell CarcinomaMartina Torchio, Laura Cattaneo, Massimo Milione, et al.
Cancers|January 11, 2022
Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET StudySara Pusceddu, Claudio Vernieri, Massimo Di Maio, et al.
Endocrine-Related Cancer|May 12, 2021
Target therapies plus somatostatin analogs in NETs: a network meta-analysisSara Pusceddu, Antonio Facciorusso, Luca Giacomelli, et al.
Tumori|May 20, 2022
Metastatic pheochromocytomas and paragangliomas: where are we?Natalie Prinzi, Francesca Corti, Martina Torchio, et al.
World Journal of Gastrointestinal Oncology|September 4, 2020
One size does not fit all for pancreatic cancers: A review on rare histologies and therapeutic approachesMonica Niger, Michele Prisciandaro, Maria Antista, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Tumori|June 13, 2020
Comparison of outcomes of central venous catheters in patients with solid and hematologic neoplasms: an Italian real-world analysisFrancesca Corti, Marta Brambilla, Sara Manglaviti, et al.
Cancers|April 10, 2019
Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-AnalysisSara Pusceddu, Michele Ghidini, Martina Torchio, et al.
The Oncologist|April 6, 2023
BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint InhibitorsRaphael Colle, Sara Lonardi, Marine Cachanado, et al.
Therapeutic Advances in Gastroenterology|August 22, 2020
The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidenceSara Pusceddu, Claudio Vernieri, Natalie Prinzi, et al.
Future Oncology (London, England)|August 20, 2019
Somatostatin analogs in association with peptide receptor radionucleotide therapy in advanced well-differentiated NETsNatalie Prinzi, Alessandra Raimondi, Marco Maccauro, et al.
Frontiers in Oncology|July 5, 2021
Case Report: Exceptional Response to Avelumab After Failure of Electrochemotherapy in a Patient With Rapidly Progressive, PD-L1-Negative Merkel Cell CarcinomaMartina Torchio, Laura Cattaneo, Massimo Milione, et al.
Cancers|January 11, 2022
Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET StudySara Pusceddu, Claudio Vernieri, Massimo Di Maio, et al.
Endocrine-Related Cancer|May 12, 2021
Target therapies plus somatostatin analogs in NETs: a network meta-analysisSara Pusceddu, Antonio Facciorusso, Luca Giacomelli, et al.
Tumori|May 20, 2022
Metastatic pheochromocytomas and paragangliomas: where are we?Natalie Prinzi, Francesca Corti, Martina Torchio, et al.
World Journal of Gastrointestinal Oncology|September 4, 2020
One size does not fit all for pancreatic cancers: A review on rare histologies and therapeutic approachesMonica Niger, Michele Prisciandaro, Maria Antista, et al.
Pageof 7